Embecta (EMBC) Long-Term Deferred Tax (2021 - 2026)
Embecta (EMBC) posted Long-Term Deferred Tax of $161.8 million for Q1 2026, down 6.2% sequentially from $172.5 million in Q4 2025, and down 17.58% YoY from $196.3 million in Q1 2025.
Embecta (EMBC) Long-Term Deferred Tax (2021 - 2026) Analysis & Trends
Embecta has reported Long-Term Deferred Tax for 6 years, with the latest figure at $161.8 million in Q1 2026.
- Quarterly Long-Term Deferred Tax fell 17.58% year-over-year to $161.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $161.8 million (down 17.58% YoY) and the FY2025 annual result came in at $179.9 million, down 14.41% from the prior year.
- Long-Term Deferred Tax retreated to $161.8 million in Q1 2026 per EMBC's latest filing, from $172.5 million in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $210.2 million in Q3 2024 and troughed at $95.5 million in Q3 2022.
- A 5-year average of $160.5 million and a median of $172.3 million in 2024 frame the typical range for Long-Term Deferred Tax.
- The sharpest annual moves came in 2022 and 2026: Long-Term Deferred Tax jumped 737.72% in 2022, then retreated 17.58% in 2026.
- Over 5 years, Long-Term Deferred Tax stood at $96.6 million in 2022, then surged by 78.78% to $172.7 million in 2023, then gained by 15.81% to $200.0 million in 2024, then decreased by 13.75% to $172.5 million in 2025, then retreated by 6.2% to $161.8 million in 2026.
- According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $161.8 million, $172.5 million, and $179.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Embecta | 305.26 Mn | 87.06 Mn | 153.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 156.00 Mn |
| Mar 31, 2026 | 161.80 Mn |
| Dec 31, 2025 | 172.50 Mn |
| Sep 30, 2025 | 179.90 Mn |
| Jun 30, 2025 | 190.40 Mn |
| Mar 31, 2025 | 196.30 Mn |
| Dec 31, 2024 | 200.00 Mn |
| Sep 30, 2024 | 210.20 Mn |
| Jun 30, 2024 | 171.40 Mn |
| Mar 31, 2024 | 172.30 Mn |
| Dec 31, 2023 | 172.70 Mn |
| Sep 30, 2023 | 140.40 Mn |
| Jun 30, 2023 | 130.90 Mn |
| Mar 31, 2023 | 116.20 Mn |
| Dec 31, 2022 | 96.60 Mn |
| Sep 30, 2022 | 95.50 Mn |
| Sep 30, 2021 | 11.40 Mn |